View More View Less
  • 1 Országos Orvosi Rehabilitációs Intézet, Budapest, 1121 Szanatórium utca 19.
Open access

Absztrakt:

A transzfúzió gyakorlata jelentősen változott az elmúlt két évtizedben. A meglévő anémia és a perioperatív szakban alkalmazott transzfúzió a betegek gyógyulási esélyét csökkentik. A vértakarékos betegellátás programját a vérzés nagy kockázatával járó elektív sebészeti műtétekhez dolgozták ki szerte a világban. A műtét előtt az anémia, az elégtelen vasraktárak és a hemosztázis zavarának kezelése, a beavatkozás okozta vérvesztés csökkentése a program legfontosabb elemei. A vértranszfúzió egy egységenként történő adásának gyakorlata, az intraoperatív vérmentés, és a masszív transzfúziós protokoll, tranexámsav használata, a gondos sebészi hemosztázis, az intraoperatív hypothermia, acidózis elkerülése a program ugyancsak kiemelkedően fontos részei. A jelenlegi ajánlások a megszorító vörösvérsejt-transzfúziós gyakorlatot javasolják a hemodinamikailag stabil sebészeti és belgyógyászati betegeknél, miszerint transzfúzió adása nem szükséges, ha a hemoglobinszint több mint 70–80 g/l. A restriktív transzfúziós gyakorlat megfelelő lehet a legtöbb, anémia tüneteit nem mutató betegnél, csökkenti a transzfúzió adásának kockázatát és nem befolyásolja hátrányosan a mortalitást és morbiditást.. A restriktív transzfúziós gyakorlat megfelelő lehet a legtöbb anémia tüneteit nem mutató betegnek, csökkenti a transzfúzió adásának kockázatát és nem befolyásolja a mortalitást és morbiditást. A vértakarékos betegellátás bevezetése csökkentette az intraoperatív vérvesztést, vérfelhasználást, kórházi kezelés idejét és javította a betegellátás eredményességét. A programot sikeresen vezették be számos európai, amerikai és ausztráliai kórházban. Nincs kétség afelől, hogy kívánatos lenne ez hazánkban is.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1

    Mohamed RS (ed). Blood conservation in the surgical patient. Williams & Wilkins, Baltimore, 1996.

  • 2

    Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis. http://www.nataonline.com (Letöltve: 2018. 08. 22).

  • 3

    National Blood Authority. Australia. Patient Blood Management Guidelines. http://www.blood.gov.au/pbm-guidelines (Letöltve: 2018. 09. 11).

  • 4

    Muñoz M, Gómez-Ramírez S, Campos A, et al. Pre-operative anaemia: prevalence, consequences and approaches to management. Blood Transfus. 2015; 13: 370–379.

  • 5

    Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in noncardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396–1407.

  • 6

    Dunne JR, Malone D, Tracy JK, et al. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res. 2002; 102: 237–244.

  • 7

    Elwood NR, Martin AN, Turrentine FE, et al. The negative effect of perioperative red blood cell transfusion on morbidity and mortality after major abdominal operations. Am J Surg. 2018; 216: 487–491.

  • 8

    Fowler AJ, Ahmad T, Phull MK, et al. Systematic review and meta-analysis between preoperative anaemia and mortality after surgery. Br J Surg 2015; 10: 1314–1324.

  • 9

    Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth. 2011; 106: 13–22.

  • 10

    Muñoz M, Acheson AG, Auerback M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72: 233–247.

  • 11

    Dignass A, Farrag K, Stein J. Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int J Chronic Dis. 2018; 2018: 9394060

  • 12

    Froessler B, Palm P, Weber I, et al. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery. A randomized controlled trial. Ann Surg. 2016; 264: 41–46.

  • 13

    Kotzé A, Harris A, Baker C, et al. British committee for standards in haematology guidelines on the identification and management of pre-operative anaemia. Br J Haematol. 2015; 171: 322–331.

  • 14

    Theusinger OM, Kind SL, Seifert B, et al. Patient blood management in orthopaedic surgery – a four year follow up from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland on transfusion requirements and blood loss. Blood Transfus. 2014; 12: 195–203.

  • 15

    Liumbruno GM, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period. Blood Transfus. 2011; 9: 19–40.

  • 16

    Australian & New Zealand Society of Blood Transfusion. Preoperative Autologous Donation (PAD). https://www.anzsbt.org.au/data/documents/ANZSBTPADstatementApr2015.pdf (Letöltve: 2018. 10. 05.)

  • 17

    Retteghy T. Autologous transfusion. In: Vezendy K. (ed) Transfusion. [Autológ transzfúzió. In: Vezendy K. (szerk.) Transzfúzió]. Medicina Könyvkiadó, Budapest, 2015; pp. 11–111.[Hungarian]

  • 18

    Vassallo R, Goldman M, Germain, Lozano M, et al. Preoperative autologous blood donation: waning indications in an era of improved blood safety. Trans Med Rev 2015; 29: 268–275.

  • 19

    Desborough MJ, Oakland KA, Landoni G, et al. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost. 2017; 15: 263–272.

  • 20

    Pabinger I, Fries D, Schöchl H, et al. Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschr. 2017; 129: 303–316.

  • 21

    Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 201620: 100.

  • 22

    Fredericks C, Kubasiak JC, Mentzer CJ, Yon JR. Massive transfusion: An update for the anesthesiologist. World J Anesthesiol. 2017; 6: 14–21.

  • 23

    Curry N, Foley C, Wong H, et al. Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial. Crit Care 2018; 22: 164

  • 24

    Curry NS, Davenport R, Pavord S, et al. The use of viscoelastic haemostatic assays in the management of major bleeding: A British Society for Haematology Guideline. Br J Haematol. 2018; 182:789–806.

  • 25

    Innerhofer P, Fries D, Mittermayr M, et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol. 2017; 4: e258–e271

  • 26

    Godier A, Greinacher A, Faraoni D. Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH. J Thromb Haemost. 2018; 16: 170–174.

  • 27

    Richman JM, Rowlingson AJ, Maine DN, et al. Does neuraxial anesthesia reduce intraoperative blood loss? A meta-analysis. J Clin Anesth. 2006; 18 :427–435.

  • 28

    Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB: Red blood cell transfusion thresholds and storage. JAMA 2016; 316: 2025–2035.

  • 29

    Roubinian NH, Hendrickson JE, Triulzi DJ, et al. Contemporary risk factors and outcomes of transfusion-associated circulatory overload. Crit Care Med. 2018; 46: 577–585.

  • 30

    Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999; 340: 409–417.

  • 31

    Shander A, Javidroozi M, Naqvi S, et al. An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion 2014; 54: 2688–2695.

  • 32

    Holst LB, Haase N, Wetterslev J, et al. Group TT, Scandinavian Critical Care Trials: Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014; 371: 1381–1391.

  • 33

    Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011; 365: 2453–2462.

  • 34

    Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007; 356: 1609–1619.

  • 35

    Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11–21.

  • 36

    East JM, Viau-Lapointe J, McCredie VA. Transfusion practices in traumatic brain injury, Curr Opin Anesthesiol. 2018; 31: 219–226.

  • 37

    Shander A, Van Aken H, Colomina MJ, et al. Patient blood management in Europe. Br J Anaesth. 2012; 109: 55–68.

  • 38

    Muñoz M, Franchini M, Liumbruno GM. The post-operative management of anaemia: more efforts are needed. Blood Transfus. 2018; 16: 324–325.

  • 39

    Khalafallah AA, Yan C, Al-Badri R, et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. Lancet Haematol. 2016; 3: e415–425.

  • 40

    Daoud E, Nakhla E, Sharma R. Q: Is iron therapy for anemia harmful in the setting of infection? Cleve Clin J Med. 2011; 78: 168–170.

  • 41

    Liumbruno GM, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period. Blood Transfus. 2011; 9: 320–335.

  • 42

    Hare GM, Mu A, Romaschin A, et al. Plasma methemoglobin as a potential biomarker of anemic stress in humans. Can J Anaesth. 2012; 59: 348–356.

  • 43

    Spolverato G, Kim Y, Ejaz A, et al. Effect of relative decrease in blood hemoglobin concentrations on postoperative morbidity in patients who undergo major gastrointestinal surgery. JAMA Surg. 2015; 150: 949–956.

  • 44

    Zeroual N, Samarani G, Gallais J, et al. ScvO2 changes after red-blood-cell transfusion for anaemia in cardiothoracic and vascular ICU patients: an observational study. Vox Sang. 2018; 113: 136–142.

  • 45

    Surve RM, Muthuchellappan R, Rao GS, Philip M. The effect of blood transfusion on central venous oxygen saturation in critically ill patients admitted to a neurointensive care unit. Transfus Med. 2016; 26: 343–348.

  • 46

    Abraham I, Sun D. The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion 2012; 52: 1983–1988.

  • 47

    Gombotz H, Hofmann A. [Patient Blood Management: three pillar strategy to improve outcome through avoidance of allogeneic blood products]. Anaesthesist 2013; 62: 519–527.

  • 48

    Meybohm P, Herrmann E, Steinbicker AU, et al. Patient blood management is associated with a substantial reduction of red blood cell utilization and safe for patient’s outcome: a prospective, multicenter cohort study with a noninferiority design. Ann Surg. 2016; 264: 203–211.

  • 49

    Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017; 57: 1347–1358.

  • 50

    European Commission. Directorate General for Health and Food Safety Health Programme. Supporting Patient Blood Management (PBM) in the EU. A Practical Implementation Guide for Hospitals. https://ec.europa.eu/health/sites/health/files/blood_tissues_organs/docs/2017_eupbm_hospitals_en.pdf (Letöltve: 2018. 09. 14.).